Journal article
The validity of cost-effectiveness analyses of tight glycemic control. A systematic survey of economic evaluations of pharmacological interventions in patients with type 2 diabetes
Abstract
PurposeCurrently available randomized trial evidence has shown no reductions in type 2 diabetes (T2D) complications important to patients with tight glycemic control. Yet, economic analyses consistently find tight glycemic control to be cost-effective. To understand this apparent paradox, we systematically identified and appraised economic analyses of tight glycemic control for T2D.MethodsWe searched multiple databases from January 2016 to …
Authors
Barrera FJ; Toloza FJ; Ponce OJ; Zuñiga-Hernandez JA; Prokop LJ; Shah ND; Guyatt G; Rodriguez-Gutierrez R; Montori VM
Journal
Endocrine, Vol. 71, No. 1, pp. 47–58
Publisher
Springer Nature
Publication Date
January 2021
DOI
10.1007/s12020-020-02489-w
ISSN
1355-008X